The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Antioxidants · 02.01.2024 · 13 (1) · 70
DOI: 10.3390/antiox13010070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 02.01.2024. Verfasst von Christophe Glorieux und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou…. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Ciencia y Tecnología (FONDECYT, Chile), “Fondo Nacional de Ciencia y Tecnología” (FONDECYT, Chile).
Abstract (Originalsprache)
Physiological concentrations of reactive oxygen species (ROS) play vital roles in various normal cellular processes, whereas excessive ROS generation is central to disease pathogenesis. The nuclear factor erythroid 2-related factor 2 (NRF2) is a critical transcription factor that regulates the cellular antioxidant systems in response to oxidative stress by governing the expression of genes encoding antioxidant enzymes that shield cells from diverse oxidative alterations. NRF2 and its negative regulator Kelch-like ECH-associated protein 1 (KEAP1) have been the focus of numerous investigations in elucidating whether NRF2 suppresses tumor promotion or conversely exerts pro-oncogenic effects. NRF2 has been found to participate in various pathological processes, including dysregulated cell proliferation, metabolic remodeling, and resistance to apoptosis. Herein, this review article will examine the intriguing role of phase separation in activating the NRF2 transcriptional activity and explore the NRF2 dual impacts on tumor immunology, cancer stem cells, metastasis, and long non-coding RNAs (LncRNAs). Taken together, this review aims to discuss the NRF2 multifaceted roles in both cancer prevention and promotion while also addressing the advantages, disadvantages, and limitations associated with modulating NRF2 therapeutically in cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
- Química y Farmacia, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique 1100000, Chile.
- Programa de Magister en Ciencias Químicas y Farmacéuticas, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique 1100000, Chile.
- Instituto de Química Medicinal, Universidad Arturo Prat, Iquique 1100000, Chile.
- Research Group in Metabolism and Nutrition, Louvain Drug Research Institute, Université Catholique de Louvain, 1200 Brussels, Belgium.
ORCID-Profile: Christophe Glorieux, Cinthya Enríquez, Gabriela Aguirre-Martínez
Förderung
- Fondo Nacional de Ciencia y Tecnología (FONDECYT, Chile)
- “Fondo Nacional de Ciencia y Tecnología” (FONDECYT, Chile)
Zitieren
APA
Glorieux, C., Enríquez, C., González, C., Aguirre-Martínez, G., & Buc Calderon, P. (2024). The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?. Antioxidants, 13(1), 70. https://doi.org/10.3390/antiox13010070
Vancouver
Glorieux C, Enríquez C, González C, Aguirre-Martínez G, Buc Calderon P. The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?. Antioxidants. 2024;13(1):70. doi:10.3390/antiox13010070
BibTeX
@article{Glorieux2024,
author = {Glorieux, Christophe and Enríquez, Cinthya and González, Constanza and Aguirre-Martínez, Gabriela and Buc Calderon, Pedro},
title = {The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {1},
pages = {70},
doi = {10.3390/antiox13010070}
}
EUVIMED